{"id":"https://openalex.org/W2170605849","doi":"https://doi.org/10.1111/j.2042-7158.1997.tb06116.x","title":"Chronic Treatment with Prazosin Causes a Subtype-specific Increase in the \u03b11-Adrenoceptor Density of the Stressed Rat Cerebral Cortex","display_name":"Chronic Treatment with Prazosin Causes a Subtype-specific Increase in the \u03b11-Adrenoceptor Density of the Stressed Rat Cerebral Cortex","publication_year":1997,"publication_date":"1997-08-01","ids":{"openalex":"https://openalex.org/W2170605849","doi":"https://doi.org/10.1111/j.2042-7158.1997.tb06116.x","mag":"2170605849","pmid":"https://pubmed.ncbi.nlm.nih.gov/9379360"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.1997.tb06116.x","doi":"https://doi.org/10.1111/j.2042-7158.1997.tb06116.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1997.tb06116.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079117338","display_name":"Manabu Takita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111966504","display_name":"University of Fukui","ror":"https://ror.org/00msqp585","country_code":"JP","type":"education","lineage":["https://openalex.org/I111966504"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Manabu Takita","raw_affiliation_strings":["Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan","institution_ids":["https://openalex.org/I111966504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100832357","display_name":"Takanobu Taniguchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111966504","display_name":"University of Fukui","ror":"https://ror.org/00msqp585","country_code":"JP","type":"education","lineage":["https://openalex.org/I111966504"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takanobu Taniguchi","raw_affiliation_strings":["Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan","institution_ids":["https://openalex.org/I111966504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083522997","display_name":"Jun Zhu","orcid":"https://orcid.org/0000-0001-9075-4866","observed_orcids":["https://orcid.org/0000-0001-9075-4866"]},"institutions":[{"id":"https://openalex.org/I111966504","display_name":"University of Fukui","ror":"https://ror.org/00msqp585","country_code":"JP","type":"education","lineage":["https://openalex.org/I111966504"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jun Zhu","raw_affiliation_strings":["Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan","institution_ids":["https://openalex.org/I111966504"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062876325","display_name":"Ikunobu Muramatsu","orcid":"https://orcid.org/0000-0002-6881-5391","observed_orcids":["https://orcid.org/0000-0002-6881-5391"]},"institutions":[{"id":"https://openalex.org/I111966504","display_name":"University of Fukui","ror":"https://ror.org/00msqp585","country_code":"JP","type":"education","lineage":["https://openalex.org/I111966504"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Ikunobu Muramatsu","raw_affiliation_strings":["Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School , Matsuoka, Fukui 910-11,","institution_ids":[]},{"raw_affiliation_string":"Department of Pharmacology, Fukui Medical School, Matsuoka, Fukui 910-11, Japan","institution_ids":["https://openalex.org/I111966504"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062876325"],"corresponding_institution_ids":["https://openalex.org/I111966504"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":0.1985,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.45143115,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"49","issue":"8","first_page":"802","last_page":"805"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.057500001043081284,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.053599998354911804,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/alpha1-adrenergic-receptors","display_name":"alpha1-adrenoceptors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/alpha1a-adrenoceptor","display_name":"alpha1A-adrenoceptor","score":0.8379999995231628},{"id":"https://openalex.org/keywords/alpha1b-adrenoceptor","display_name":"alpha1B-adrenoceptor","score":1.0},{"id":"https://openalex.org/keywords/receptor-subtype-specificity","display_name":"receptor subtype specificity","score":0.628000020980835},{"id":"https://openalex.org/keywords/restraint-stress","display_name":"restraint stress","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cerebral-cortex","display_name":"cerebral cortex","score":0.7910000085830688},{"id":"https://openalex.org/keywords/chronic-drug-administration","display_name":"chronic drug administration","score":0.7680000066757202},{"id":"https://openalex.org/keywords/receptor-density","display_name":"receptor density","score":0.7440000176429749},{"id":"https://openalex.org/keywords/adrenergic-receptors","display_name":"adrenergic receptors","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.9975916147232056},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.693261444568634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5086177587509155},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.49132075905799866},{"id":"https://openalex.org/C40465926","wikidata":"https://www.wikidata.org/wiki/Q410568","display_name":"Adrenergic receptor","level":3,"score":0.4591834247112274},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39289334416389465},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3795315623283386},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.269229531288147},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.12401095032691956},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.07108226418495178},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000648","qualifier_name":"ultrastructure","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012149","descriptor_name":"Restraint, Physical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013312","descriptor_name":"Stress, Physiological","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014316","descriptor_name":"Tritium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.2042-7158.1997.tb06116.x","doi":"https://doi.org/10.1111/j.2042-7158.1997.tb06116.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1997.tb06116.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:9379360","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9379360","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322555","display_name":"Smoking Research Foundation","ror":"https://ror.org/04q4hbm31"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W74054093","https://openalex.org/W640079138","https://openalex.org/W1841809633","https://openalex.org/W1865252654","https://openalex.org/W1970580461","https://openalex.org/W1972067292","https://openalex.org/W1977638218","https://openalex.org/W1984030153","https://openalex.org/W1989290237","https://openalex.org/W1990033171","https://openalex.org/W1992368540","https://openalex.org/W1995745962","https://openalex.org/W1996897799","https://openalex.org/W2000360015","https://openalex.org/W2006141974","https://openalex.org/W2025346855","https://openalex.org/W2043813981","https://openalex.org/W2048275569","https://openalex.org/W2048373362","https://openalex.org/W2051286763","https://openalex.org/W2060404435","https://openalex.org/W2065683475","https://openalex.org/W2075688573","https://openalex.org/W2092028537","https://openalex.org/W2104559308","https://openalex.org/W2128635872","https://openalex.org/W2155318267","https://openalex.org/W2258115004","https://openalex.org/W2345809758","https://openalex.org/W6719694032","https://openalex.org/W6785863821"],"related_works":["https://openalex.org/W3105894761","https://openalex.org/W3104051686","https://openalex.org/W1998021465","https://openalex.org/W1996897799","https://openalex.org/W1987265099","https://openalex.org/W1974754068","https://openalex.org/W2037697488","https://openalex.org/W1976990373","https://openalex.org/W2036322487","https://openalex.org/W1985107177"],"abstract_inverted_index":{"The":[0,46,148],"effects":[1],"of":[2,8,36,50,90,106,123,136,141,145,150,170],"chronic":[3,84],"treatment":[4,85,112,165,197],"with":[5,59,72,86,113,118,126,132,156,166,174,198],"prazosin":[6,37,51,91,114,137,160,171,199],"and":[7,63,153,189,200],"immobilization":[9],"stress":[10,77,119,146],"on":[11],"the":[12,97,103,121,139],"alpha":[13,107,124,142,151,154,182,185,187,190],"1-adrenoceptor":[14,108,183],"subtypes":[15],"in":[16,56,69,96,102,172],"rat":[17],"cerebral":[18],"cortex":[19],"have":[20],"been":[21],"examined.":[22],"Prazosin-treated":[23],"rats":[24],"were":[25,52,161],"allowed":[26],"free":[27],"access":[28],"to":[29],"tap":[30],"water":[31],"containing":[32],"two":[33],"different":[34],"concentrations":[35,49],"(16":[38],"or":[39,65,83,101],"156":[40],"mg":[41],"L-1)":[42],"for":[43,99,129,159],"5":[44,53],"weeks.":[45],"mean":[47],"plasma":[48],"ng":[54,67],"mL-1":[55,68],"groups":[57],"treated":[58,71],"a":[60,73,87,133,167],"low":[61,88,127],"dose":[62,89,135,169],"8":[64],"14":[66],"those":[70],"high":[74,134,157,168],"dose.":[75],"Immobilization":[76],"(2":[78],"h":[79],"day-1,":[80],"2":[81],"weeks)":[82],"caused":[92],"no":[93],"significant":[94],"change":[95],"affinity":[98,128,158],"[3H]prazosin":[100],"maximum":[104],"number":[105],"sites":[109],"(Bmax).":[110],"However,":[111],"(low":[115],"dose)":[116],"combined":[117],"increased":[120,138,162],"density":[122,140],"1-adrenoceptors":[125],"prazosin.":[130],"Treatment":[131],"1L-adrenoceptors,":[143],"irrespective":[144],"loading.":[147],"densities":[149],"1A-":[152],"1B-adrenoceptors":[155],"only":[163],"after":[164],"combination":[173],"stress.":[175,202],"These":[176],"results":[177],"indicate":[178],"that":[179],"three":[180],"distinct":[181],"subtypes,":[184],"1A,":[186],"1B":[188],"1L,":[191],"might":[192],"be":[193],"affected":[194],"differently":[195],"by":[196,201]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}